DK2417152T3 - Fremgangsmåde til isolering af linaclotid - Google Patents

Fremgangsmåde til isolering af linaclotid

Info

Publication number
DK2417152T3
DK2417152T3 DK10715185.4T DK10715185T DK2417152T3 DK 2417152 T3 DK2417152 T3 DK 2417152T3 DK 10715185 T DK10715185 T DK 10715185T DK 2417152 T3 DK2417152 T3 DK 2417152T3
Authority
DK
Denmark
Prior art keywords
linaclotide
isolating
isolating linaclotide
Prior art date
Application number
DK10715185.4T
Other languages
English (en)
Inventor
Michael Paul Fleming
Raymond Dennis Petersen
Original Assignee
Corden Pharma Colorado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42289374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2417152(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corden Pharma Colorado Inc filed Critical Corden Pharma Colorado Inc
Application granted granted Critical
Publication of DK2417152T3 publication Critical patent/DK2417152T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
DK10715185.4T 2009-04-10 2010-04-07 Fremgangsmåde til isolering af linaclotid DK2417152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16825909P 2009-04-10 2009-04-10
PCT/EP2010/054577 WO2010115916A1 (en) 2009-04-10 2010-04-07 Process for isolating therapeutic peptide

Publications (1)

Publication Number Publication Date
DK2417152T3 true DK2417152T3 (da) 2013-12-16

Family

ID=42289374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10715185.4T DK2417152T3 (da) 2009-04-10 2010-04-07 Fremgangsmåde til isolering af linaclotid

Country Status (7)

Country Link
US (1) US20100261877A1 (da)
EP (1) EP2417152B1 (da)
CN (1) CN102482326A (da)
DK (1) DK2417152T3 (da)
ES (1) ES2439998T3 (da)
IL (1) IL215562A0 (da)
WO (1) WO2010115916A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748575B2 (en) * 2010-06-09 2014-06-10 Combimab, Inc. Therapeutic peptides
EA201391254A1 (ru) * 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
JP2016521249A (ja) * 2012-07-12 2016-07-21 フォレスト ラボラトリーズ ホールディングス リミテッド リナクロチド組成物
CN103848893B (zh) * 2012-12-07 2016-08-10 深圳翰宇药业股份有限公司 一种利那洛肽的纯化方法
WO2014118180A1 (en) 2013-01-30 2014-08-07 Sandoz Ag Crystalline form of linaclotide
CN104231051B (zh) * 2013-06-06 2020-06-26 深圳翰宇药业股份有限公司 一种利那洛肽的制备方法
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2016012938A2 (en) * 2014-07-22 2016-01-28 Dr. Reddy’S Laboratories Limited Improved process for preparation of amorphous linaclotide
WO2014188011A2 (en) * 2014-09-25 2014-11-27 Lonza Ltd Method for preparation of linaclotide
CN110878118B (zh) * 2018-09-06 2023-04-18 深圳翰宇药业股份有限公司 度拉糖肽的纯化方法与纯化试剂
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
KR100464208B1 (ko) * 2001-12-20 2005-01-03 엘지.필립스 엘시디 주식회사 액정 표시장치 및 그 구동방법
SE0104462D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)
US20040028747A1 (en) * 2002-08-06 2004-02-12 Tucker Christopher J. Crystalline drug particles prepared using a controlled precipitation process
KR101227626B1 (ko) * 2003-01-28 2013-02-01 아이언우드 파마슈티컬스, 인코포레이티드 위장병 치료 방법 및 위장병 치료용 조성물
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7371727B2 (en) 2003-01-28 2008-05-13 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
WO2010115916A1 (en) 2010-10-14
US20100261877A1 (en) 2010-10-14
IL215562A0 (en) 2011-12-29
EP2417152B1 (en) 2013-10-02
EP2417152A1 (en) 2012-02-15
CN102482326A (zh) 2012-05-30
ES2439998T3 (es) 2014-01-27

Similar Documents

Publication Publication Date Title
DK2417152T3 (da) Fremgangsmåde til isolering af linaclotid
DK2408561T3 (da) Fremgangsmåde til isolering af partikler
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
FI20090389A0 (fi) Menetelmä
DK2513135T3 (da) Fremgangsmåde til oprensning af polypeptider
DK2601542T3 (da) Fremgangsmåde til at adskille uafhængige samtidige kilder
DK2283904T3 (da) Komponentsystem
EP2401047A4 (en) SEPARATION PROCESS
DK3730045T3 (da) Fremgangsmåde til indføring af en analytsensor
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
DK2509427T3 (da) Fremgangsmåder til fremstilling af GH8-xylanasevarianter
DK2580156T4 (da) Fremgangsmåde til lagring af hydrogen
DK3543333T3 (da) Fremgangsmåde til screening af alfa-amylaser
BRPI0919116A2 (pt) método
DK2398817T4 (da) Fremgangsmåde til rensning af lipopeptider
EP2509515A4 (en) WITHERS
BRPI1012526A2 (pt) método
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2501890T3 (da) Kvældbart forbindelsessystem og fremgangsmåde til anvendelse af dette
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
BRPI1010705A2 (pt) método
DK2557988T3 (da) System til forudsigelse af gastrointestinal dysfunktion
DK2313489T3 (da) Fremstillingsmetode